NGM Biopharmaceuticals, Inc.
Methods of treating fibroblast growth factor 19-mediated cancers and tumors

Abstract:

Provided are methods of treating a FGF19-mediated cancer or tumor in a subject by administering to the subject an anti-IL-6 antibody or an anti-IL-6 receptor antibody or an inhibitor of STAT3/JAK signaling pathway, and pharmaceutical compositions relating thereto.